Organogenesis Holdings Inc. rose 11.5% on Monday, November 9, 2026, on 861,196 shares. No headline about ORGO came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Organogenesis Holdings Inc. (ORGO:NASDAQ) closed at $0.907 on November 9, 2026, up 11.55% on the day. The stock trades 87.2% below its 52-week high of $7.08 and 24.3% above its 52-week low of $0.730. Over the past year, it lost 85.6%. Organogenesis Holdings Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 7, 2025, ORGO closed higher on 90 days (36%). Its best day was November 7, 2025 (+44.73%) and its worst was August 7, 2026 (-22.82%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.
Organogenesis Holdings Inc, formerly Avista Healthcare Public Acquisition Corp is a regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets.
Find more stocks like ORGO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.